Skip to main content

With 7.1% CAGR, US Dermal Fillers Market Worth USD 3.61 Billion by 2029

Written by Customer Service on . Posted in Mergers And Acquisitions.

According to Fortune Business Insights, the global US Medical Devices Market size is projected to reach USD 3.61 Billion by 2029, at a CAGR of 7.1% during the forecast period, 2022-2029

Pune, India, Dec. 06, 2022 (GLOBE NEWSWIRE) — The US Dermal Fillers Market size was USD 2.13 billion in 2021. The market is expected to expand from USD 2.24 billion in 2022 to USD 3.61 billion by 2029, exhibiting a CAGR of 7.1% from 2022 to 2029. The industry growth is being driven by increasing R&D initiatives and the launch of new products.

Fortune Business Insights™ cites this information in its research report, titled “US Dermal Fillers Market, 2022-2029”.

Key Industry Development:

April 2022 – Allergan Aesthetics rolled out HArmonyCa. This constituted a dual effect hybrid injectable with hyaluronic acid, two active ingredients, and calcium hydroxyapatite.


Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-dermal-fillers-market-107015


Report Coverage:

The report provides an in-depth analysis of the prominent trends that are set to propel the industry landscape over the forthcoming years. It further gives an overview of the major steps taken by leading companies for strengthening their industry presence. These insights have been provided after comprehensive research and data collation from credible sources.

COVID-19 Impact:

Industry Value Affected Owing to Cancellation of Elective Procedures

The COVID-19 pandemic impacted the market growth driven by the closure of dermatology clinics and elective procedures. The product demand was further affected by the decrease in revenue due to disruptions in supply chain and manufacturing operations. However, the lifting of lockdown restrictions in the subsequent period propelled the US Dermal Fillers Market share over the forecast period.

Drivers and Restraints:

Market Share to Surge Due to Growing Demand for Minimally Invasive Procedures

The US Dermal Fillers Market growth is being impelled by the escalating demand for minimally invasive procedures. The rise can be credited due to the surging inclination of people toward hassle free methods for the improvement of aesthetic appearance.

However, the industry expansion could be hampered by the biodegradable nature of products, the need for repeated treatments, and the soaring economic burden on patients.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/u-s-dermal-fillers-market-107015



Segments:

Hyaluronic Acid Segment to Register Substantial Expansion Owing to Rising Launch of New Products

Based on material, the market is segmented into calcium hydroxylapatite, hyaluronic acid, fat fillers, poly-l-lactic acid, PMMA, and others. The hyaluronic acid segment is expected to record a notable surge through the forecast period. The surge can be attributed to the rising number of product launches.

Biodegradable Segment to Record Commendable Growth Due to Increasing Product Adoption

Based on product, the U.S. market for dermal fillers is fragmented into non-biodegradable and biodegradable. Of these, the biodegradable segment is projected to register appreciable growth over the study period. The rise is being driven by a broad range of benefits such as efficacy and safety and the extensive availability of products.

Wrinkle Correction Segment to Exhibit Notable Rise Driven by Increasing R&D Initiatives

Based on application, the market can be subdivided into lip enhancement, scar treatment, restoration of volume/fullness, wrinkle correction, and others. Of these, the wrinkle correction segment is estimated to record a considerable CAGR throughout the analysis period. The rise can be credited to the growing investments for extensive research and development.


Quick Buy – US Dermal Fillers Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/107015


Competitive Landscape:

Leading Companies to Enter into Partnership Agreements to Strengthen their Positions

Prominent dermal fillers companies are focused on the adoption of a series of strategic initiatives for gaining a strong footing. The initiatives include mergers, acquisitions, product developments, and others. Besides, several industry participants are entering into collaborations and partnership agreements for strengthening their market position.

List of Key Players Mentioned in the Report:

  • Allergan Aesthetics (AbbVie Inc.) (U.S.)
  • Revance Therapeutics, Inc. (U.S.)
  • Merz Pharma (Germany)
  • GALDERMA (Switzerland)
  • Suneva Medical (U.S.)
  • Prollenium Medical Technologies (Canada)
  • Bioxis pharmaceuticals (France)
  • Sinclair (U.K.)


Speak To Our Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-dermal-fillers-market-107015


Table of Contents

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Overview of the Dermal Filler Procedures, U.S.
    • Overview of Price Analysis of Types of Dermal Fillers
    • Overview of Regulatory Scenario, U.S.
    • Overview of Reimbursement Scenario, U.S.
    • New Product Launches, Key Players
    • Pipeline Analysis, Key Players
    • Impact of COVID-19 On the U.S. Dermal Fillers Market
  • U.S Dermal Fillers Market Analysis, Insights and Forecast, 2018-2029
    • Market Analysis, Insights and Forecast – By Material
      •   Hyaluronic Acid
      •   Calcium Hydroxylapatite
      •   Poly-L-lactic Acid
      •   PMMA (Poly(methyl methacrylate))
      •   Fat Fillers
      •   Others
    • Market Analysis, Insights and Forecast – By Product
      •   Biodegradable
      •   Non-Biodegradable
    • Market Analysis, Insights and Forecast – By Application
      •   Scar Treatment
      •   Wrinkle Correction Treatment
      •   Lip Enhancement
      •   Restoration of Volume/ Fullness
      •   Others
    • Market Analysis, Insights and Forecast – By End User
      •   Specialty & Dermatology Clinics
      •   Hospitals & Clinics
      •   Others
  • Competitive Analysis
    • Market Share Analysis (2021)
    • Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      •   Allergan (AbbVie, Inc.)
      •   Revance Therapeutics, Inc.
      •   Merz Pharma
      •   Galderma laboratories
      •   Sinclair Pharma
      •   Bioxis Pharmaceuticals
      •   Prollenium Medical Technologies
      •   Suneva Medical


Ask for Customization of this Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-dermal-fillers-market-107015


About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

Contact Us:

Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner – Mahalunge Road,

Baner, Pune-411045,

Maharashtra, India

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.